| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/18/2003 | WO2003075920A1 Eye drops containing tetrazole derivative |
| 09/18/2003 | WO2003075857A2 Amino-methyl substituted tetracycline compounds |
| 09/18/2003 | WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 09/18/2003 | WO2003075670A1 Treatment and prevention of inflammatory disorders |
| 09/18/2003 | WO2003059252A3 Use of a novel cell surface protease from group b streptococcus |
| 09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
| 09/18/2003 | WO2003053368A3 Chalcone derivatives and their use to treat diseases |
| 09/18/2003 | WO2003047521A3 Composition and method for treatment of otitis media |
| 09/18/2003 | WO2003005941A3 Insert for the treatment of dry eye |
| 09/18/2003 | WO2002095704A8 Use of nf-kappa-b inhibitors to treat dry eye disorders |
| 09/18/2003 | WO2002083700B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 09/18/2003 | WO2002083184A3 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 09/18/2003 | WO2002062750A9 Cannabinoid receptor ligands |
| 09/18/2003 | WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease |
| 09/18/2003 | US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 09/18/2003 | US20030176504 Administering a therapeutically effective amount of an alpha2delta ligand other than gabapentin or tiagabine, or pharmaceutically acceptable salt thereof |
| 09/18/2003 | US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/18/2003 | US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders |
| 09/18/2003 | US20030176479 Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension |
| 09/18/2003 | US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/18/2003 | US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally |
| 09/18/2003 | US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin |
| 09/18/2003 | US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 09/18/2003 | US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases |
| 09/18/2003 | US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/18/2003 | US20030176441 Inhibitsthe binding of eotaxin to the CCR-3 receptor and thereby provide a means of combating eosinophil induced diseases, such as asthma |
| 09/18/2003 | US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases |
| 09/18/2003 | US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 09/18/2003 | US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 09/18/2003 | US20030176418 For therapy of Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's chorea, Friederich's ataxia, Gilles de la Tourette's Syndrome, Down Syndrome, Pick disease, dementia, clinical depression, age- related cognitive decline |
| 09/18/2003 | US20030176417 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds |
| 09/18/2003 | US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors |
| 09/18/2003 | US20030176413 Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 09/18/2003 | US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man |
| 09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
| 09/18/2003 | US20030175849 Identifying compounds for treating vision defects associated with intraocular pressure |
| 09/18/2003 | US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents |
| 09/18/2003 | US20030175309 Adjuvants for use in vaccines |
| 09/18/2003 | US20030175308 Adjuvants for use in vaccines |
| 09/18/2003 | US20030175299 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections; stable oil-in-water emulsions, side effect reduction |
| 09/18/2003 | US20030175298 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections |
| 09/18/2003 | US20030175282 Photodynamic therapy comprising administering angiogenesis factor antagonists and photosensitizers then irradiating with lasers, for prophylaxis of vision defects |
| 09/18/2003 | US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 09/18/2003 | US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 09/18/2003 | US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases |
| 09/18/2003 | US20030175259 Use of corneal hardening agents in enzymeorthokeratology |
| 09/18/2003 | US20030175258 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 09/18/2003 | US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy |
| 09/18/2003 | CA2482191A1 Spiro compounds with npy antagonistic activity |
| 09/18/2003 | CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 09/18/2003 | CA2479036A1 Aryl substituted pyrimidines and the use thereof |
| 09/18/2003 | CA2479016A1 Quinazoline compounds useful in therapy |
| 09/18/2003 | CA2478942A1 An optically active pyridine derivative and a medicament containing the same |
| 09/18/2003 | CA2478931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 09/18/2003 | CA2478921A1 Novel chalcone derivatives and uses thereof |
| 09/18/2003 | CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity |
| 09/18/2003 | CA2478685A1 Ophthalmic solutions containing tetrazole derivatives |
| 09/18/2003 | CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 09/18/2003 | CA2478599A1 Salts of nateglinide |
| 09/18/2003 | CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis |
| 09/18/2003 | CA2478245A1 Treatment and prevention of inflammatory disorders |
| 09/18/2003 | CA2478065A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/17/2003 | EP1344535A2 Combined angiotensin II antagonists and adrenaline receptor blockers for treatment of glaucoma |
| 09/17/2003 | EP1344534A2 Combined angiotensin II antagonists and carbonic anhydrase inhibitors for treatment of glaucoma |
| 09/17/2003 | EP1344526A1 Preventives/ermedies for inflammatory airway diseases |
| 09/17/2003 | EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 09/17/2003 | EP1343803A2 2-substituted estrogens as antiangiogenic agents |
| 09/17/2003 | EP1343784A2 Urea substituted imidazoquinoline ethers |
| 09/17/2003 | EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/17/2003 | EP1343779A2 Novel compounds |
| 09/17/2003 | EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 09/17/2003 | EP1343764A1 Urea and urethane derivatives as integrin inhibitors |
| 09/17/2003 | EP1343763A1 Pyrodone derivatives as ap2 inhibitors |
| 09/17/2003 | EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands |
| 09/17/2003 | EP1343757A1 Indole derivatives |
| 09/17/2003 | EP1343561A1 Serine protease inhibitors |
| 09/17/2003 | EP1343532A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 09/17/2003 | EP1343529A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 09/17/2003 | EP1343520A2 New therapeutic uses of smr1 peptides |
| 09/17/2003 | EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 09/17/2003 | EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 09/17/2003 | EP1343511A1 Shark meat extract |
| 09/17/2003 | EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 09/17/2003 | EP1343505A1 Cxcr3 antagonists |
| 09/17/2003 | EP1343492A2 Treatment of mucositis |
| 09/17/2003 | EP1343491A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 09/17/2003 | EP1343488A1 Treatment of statin side effects |
| 09/17/2003 | EP1343474A2 Intraocular irrigating solution having improved flow characteristics |
| 09/17/2003 | EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 09/17/2003 | EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 09/17/2003 | EP1200445B1 Thienopyranecarboxamide derivatives |
| 09/17/2003 | EP1192163B1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 09/17/2003 | EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 09/17/2003 | EP0996446B1 Novel substituted imidazole compounds |
| 09/17/2003 | EP0910566B1 Heterocyclic compounds and their preparation and use |
| 09/17/2003 | EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 09/17/2003 | EP0769940B1 INDENE sPLA2 INHIBITORS |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443190A Matrix metalloproteinase inhibitors |
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |